Premium
Serum β–carotene, vitamin E, vitamin C and malondialdehyde levels in several types of cancer
Author(s) -
Torun M.,
Yardim S.,
Gönenç A.,
Sargin H.,
Menevse A.,
Simsek B.
Publication year - 1995
Publication title -
journal of clinical pharmacy and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.622
H-Index - 73
eISSN - 1365-2710
pISSN - 0269-4727
DOI - 10.1111/j.1365-2710.1995.tb00660.x
Subject(s) - malondialdehyde , medicine , vitamin c , ascorbic acid , vitamin e , vitamin , cancer , confounding , carotene , carotenoid , endocrinology , gastroenterology , antioxidant , chemistry , biochemistry , oxidative stress , food science
SUMMARY We measured the levels of serum carotenoids (β–carotene), total tocopherol (vitamin E), ascorbic acid and malondialdehyde (MDA) in newly diagnosed cancer cases. Levels of the antioxidants and MDA in serum samples from 208 subjects with cancer affecting different sites (59 breast, 38 head and neck, 46 genitourinary, 12 lung, 20 gastrointestinal and 33 other sites) were compared with levels in 156 controls. Cases and controls were compared with respect to a number of potentially confounding factors: age, sex, smoking status, Quetelet index (kg/m 2 ), diet and alcohol intake. Mean (±SD) levels of β–carotene, vitamin E and vitamin C were significantly lower among the cases than the controls (49 35±36 55 μg/1, 0 60±014 mg/dl, 0 40±0 27 mg/dl and 75 31±28 59 mg/dl, 0 98±0 13 mg/dl, 0 88±0 47 mg/dl, respectively) ( P < 0 05). On the other hand, mean levels of MDA were significantly higher among the cases than the controls (6 79±1 22 nmol/ml and 3 52±0 97nmol/ml, respectively) ( P < 0 05). The results obtained suggest that measurement of serum antioxidants and MDA levels may provide further useful information when evaluating cancer patients.